Teratogen-induced limb defects

American Journal of Medical Genetics

Volumn 112, Issue 3, 2002, Pages 297-303

  Holmes, Lewis B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Limb deficiency; Teratogens; Vascular disruption

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; MISOPROSTOL; PHENYTOIN; PROSTAGLANDIN E1 DERIVATIVE; TERATOGENIC AGENT; THALIDOMIDE; VALPROATE SEMISODIUM; VALPROIC ACID; WARFARIN;

ABDOMINAL INJURY; AMNIOCENTESIS; CHORION VILLUS SAMPLING; CIGARETTE SMOKING; COCAINE DEPENDENCE; CONFERENCE PAPER; CONTROLLED STUDY; FETAL ALCOHOL SYNDROME; FETUS; FOOT MALFORMATION; HAND MALFORMATION; HUMAN; INFANT; LIMB DEFECT; LIMB MALFORMATION; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; PLACENTA; POLYDACTYLY; PREGNANCY; PRIORITY JOURNAL; TERATOGENESIS;

CHORIONIC VILLI SAMPLING; FEMALE; HUMANS; LIMB DEFORMITIES, CONGENITAL; MALE; MISOPROSTOL; PHENYTOIN; PREGNANCY; PREGNANCY IN DIABETICS; SUBSTANCE-RELATED DISORDERS; TERATOGENS; THALIDOMIDE; VALPROIC ACID; WARFARIN;

EID: 0037108137     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.10781     Document Type: Conference Paper

References (72)

1. Ardinger HH, Atkin JF, Blackston RD, Elsas LJ, Clarren SK, Livingstone S, Flannery DB, Pellock JM, Harrod MJ, Lammer EJ, et al. 1988. Verification of the fetal valproate syndrome phenotype. Am J Med Genet 29:171-185.
2. Azarbayjani F, Danielsson BR. 2001. Phenytoin induced cleft palate: evidence for embryonic cardiac bradyarrhythmia due to inhibition of delayed rectifier K+ channels resulting in hypoxia-reoxygenation damage. Teratology 63:152-160.
3. Barr JM, Burdi AR. 1976. Warfarin-associated embryopathy in a 17-week old abortus. Teratology 14:129-134.
4. Bjerkedal T, Czeizel A, Goujard J, Kallen B, Mastroiacova P, Nevin N, Oakley JG, Robert E. 1982. Valproic acid and spina bifida. Lancet 2:1096.
5. Bokhari A, Connolly S, Harvey EA, Holmes LB. 1998. Effects on toes produced by prenatal exposure to antiepileptic drugs (AED) are common, but subtle. Teratology 57:55.
6. Bokhari A, Coull B, Holmes LB. 2002. Effect of prenatal exposure to anticonvulsant drugs on dermal ridge patterns of fingers. Teratology 66:19-23.
7. Brumback BA, Holmes LB, Ryan LM. 1999. Adverse effects of chorionic villus sampling: meta-analysis. Stat Med 18:2163-2175.
8. Buehler BA, Delimont D, van Waes M, Finnell RH. 1990. Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med 322:1567-1572.
9. Burton BK, Schulz CJ, Burd LI. 1992. Limb anomalies associated with chorionic villus sampling. Lancet 79:726-730.
10. Clarren SK, Smith DW. 1978. The fetal alcohol syndrome. N Engl J Med 298:1063-1067.
11. Coelho K-EFA, Sarmento MvF, Veiga CM, Speck-Martins CE, Safatle HPN, Castro CV, Niikawa N. 2000. Misoprostol embryotoxicity: clinical evaluation of fifteen patients with arthrogryposis. Am J Med Genet 95:297-301.
12. Costa SH, Vessey MP. 1993. Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet 341:1258-1261.
13. Crain LS, Fitzmaurice NE, Mondry C. 1983. Nail dysplasia and fetal alcohol syndrome: case report of a heteropaternal sibship. Am J Dis Child 137:1069-1072.
14. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV. 2001. Loss of caveolae, vascular dysfunction, and pulmonary defects in Caveolin-1 gene-disrupted mice. Science 293:2449-2452.
15. Faiella A, Wernig M, et al. 2000. A mouse model for valproate teratogenicity: prenatal effects, homeotic transformations, and altered HOX expression. Hum Mol Gen 9:227-236.
16. Fantel AG. 1996. Reactive oxygen species in developmental toxicity: review and hypothesis. Teratology 53:196-217.
17. Firth HV, Boyd PA, et al. 1991. Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation. Lancet 337:762-763.
18. Franco B, Meroni G, et al. 1995. A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy. Cell 81:15-25.
19. Gonazlez CH, Marques-Dias MJ, et al. 1998. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 351:1624-1627.
20. Hall JG. 1996. Arthrogryposis (AMC) associated with unsuccessful attemps at termination of pregnancy. Am J Med Genet 63:293-300.
21. Hall J, Pauli RM, Wilson KM. 1980. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68:122-140.
22. Holmes LB. 1993. Report of National Institute of Child Health and Human Development Workshop on chorionic villus sampling and limb and other defects, October 20, 1992. Teratology 48:7-13.
23. Holmes LB. 1995. Possible fetal effects of cervical dilation and uterine curettage during the first trimester of pregnancy. J Pediatr 126:131-134.
24. Holmes LB. 1997. Severe malformation of one foot from amniocentesis needle injury. Clin Dys 6:273-280.
25. Holmes LB, Haevey EA, et al. 2001. The teratogenicity of anticonvulsant drugs. N Engl J Med 344:1132-1138.
26. Howe AM, Webster WS. 1992. The warfarin embryopathy: a rat model showing maxillonasal hypoplasia and other skeletal disturbance. Teratology 46:379-390.
27. Hoyme HE, Jones KL, et al. 1990. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 85:743-747.
28. Iturbe-Alessio I, Fonseca MDC, et al. 1986. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 315:1390-1393.
29. Johnston MV, Trescher WH, et al. 2001. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr Res 49:735-741.
30. Kallen K. 1997. Maternal smoking during pregnancy and limb reduction malformations in Sweden. Am J Public Health 87:29-32.
31. Kelly TE. 1984. Teratogenicity of anticonvulsant drugs: III, radiographic hand analysis of children exposed in utero to diphenylhydantoin. Am J Med Genet 19:445-450.
32. Kozma C. 2001. Valproic acid embryopathy: report of two siblings with further expanson of the phenotypic abnormalities and a review of the literature. Am J Med Gen 98:168-175.
33. Lamb MP. 1975. Gangrene of a fetal limb due to amniocentesis. Br J Obstet Gynaecol 82:829-830.
34. Lenz W. 1966. Malformations caused by drugs in pregnancy. Am J Dis Child 112:99-106.
35. Lenz W. 1971. How can the teratogenic action of a factor be established in man? So Med J 64(Suppl 1):41-50.
36. Leong S, Ashwell KWS. 1997. Is there a zone of vascular vulnerability in the fetal brain stem? Neurotox Terat 19:265-275.
37. Light TR, Ogden JA. 1993. Congenital constriction band syndrome: pathophysiology and treatment. Yale J Biol Med 66:143-155.
38. Lipson AH. 1992. Thalidomide retrospective: what did the clinical teratologist learn? Teratology 46:411-413.
39. Los FJ, Brandenburg H, et al. 1999. Vascular disruptive syndromes after exposure to misoprostol or chorionic villus sampling. Lancet 353:843-844.
40. Lu MCK, Sammel MD, Cleveland RH. 2000. Digit effects produced by prenatal exposure to antiepileptic drugs. Teratology 61:277-283.
41. Lundberg YW, Green KA, et al. 2000. Mapping of a chromosomal locus for valproic acid-induced neural tube defects. Am J Hum Genet 67(Suppl 2):20.
42. Mahoney MJ. 1991. Limb abnormalities and chorionic villus sampling. Lancet 337:1422-1423.
43. Marques-Dias MJ, Rosenberg S, et al. 1999. Möbius sequence and arthrogryposis in children exposed to misoprostol in the first trimester of pregnancy: further evidence in support of vascular pathogenesis. Proc Greenwood Genetic Center 18:94-95.
44. Martinez-Frias ML. 1994. Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 51:108-113.
45. McGuirk CK, Westgate M-N, et al. 2001. Limb deficiencies in newborn infants. Pediatrics 108:64-76.
46. Miller MT. 1991. Thalidomide embryopathy: a model for the study of congenital incomitant horizontal strabismus. Trans Am Ophthalmol Soc 89:623-674.
47. Miller MT, Stromland K, Gillberg C, Johansson M, Wentz Nilsson E. 1998. The puzzle of autism: an ophthalmologic contribution. Tr Am Ophth Soc 96:369-387.
48. National Institute of Child Health and Human Development. 1993. Report of National Institute of Child Health and Human Development workshop on chorionic villus sampling and limb and other defects, 20 October 1992.
49. Olney RS, Khoury MJ, et al. 1995. Increased risk for transverse digital deficiency after chorionic villus sampling: results of the United States multistate case-control study, 1988-1992. Teratology 51:20-29.
50. Omtzigt JGC, Los FJ, et al. 1992. The risk of spina bifida aperta after firsttrimester exposure to valproate in a prenatal cohort. Neurology 42(Suppl 5):119-125.
51. Pauli RM, Lian JB, et al. 1987. Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives. Am J Hum Genet 41:566-583.
52. Quintero RA, Romero R, et al. 1992. Fetal hemorrhagic lesions after chorionic villus sampling. Lancet 339:193.
53. Robert E, Guibaud P. 1982. Maternal valproic acid and congenital neural tube defects. Lancet 2:937.
54. Rodriquez-Pinilla E, Arroyo I, et al. 2000. Prenatal exposure to valproic acid during pregnancy and limb deficiencies: a case-control study. Am J Med Genet 90:376-381.
55. Roze JM, Tschupp MJ, et al. 1989. Interruption selective de grossesses et malformations embryonnaires des extremites. J Gynecol Obstet Biol Reprod 18:673-677.
56. Sabry MA, Farag TI. 1996. Hand anomalies in fetal-hydantoin syndrome: from nail/phalangeal hypoplasia to unilateral acheiria. Am J Med Genet 62:410-412.
57. Scolnik D, Nulman I, Rovet J, Gladstone D, Czuchta D, Gardner HA, Gladstone R, Ashby P, Weksberg R, Einarson T, Koren G. 1994. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 271:767-770.
58. Semenza GL. 2001. Hypoxia-inducible factor 1: control of oxygen homeostosis in health and disease. Pediatr Res 49:614-617.
59. Sharony R, Garber A, et al. 1993. Preaxial ray reduction defects as part of valproic acid embryopathy. Prenatal Diagn 13:909-918.
60. Shaul WL, Hall JG. 1977. Multiple congenital anomalies associated with oral anticoagulants. Am J Obstet Gynecol 127:191-198.
61. Shepard TH. 1995. Mobius syndrome after misoprostol: a possible teratogenic mechanism. Lancet 346:780.
62. Smithells RW. 1973. Defects and disabilities of thalidomide children. Br Med J 1:169-272.
63. Smithells RW, Newman CGH. 1992. Recognition of thalidomide defects. J Med Genet 29:716-723.
64. Stephens T, Brynner R, 2001. Dark remedy: the impact of thalidomide and its revival as a vital medicine. New York: Perseus.
65. Stephens TD, Fillmore BJ. 2000. Hypothesis: thalidomide embryopathyproposed mechanism of action. Teratology 61:189-195.
66. Stoler JM, McGuirk CK, et al. 1999. Malformations reported in chorionic villus sampling exposed children: a review and analytic synthesis of the literature. Genet Med 1:315-322.
67. Strickler SM, Dansky LV, et al. 1985. Genetic predisposition to phenytoin-induced birth defects. Lancet 2:746-749.
68. Thijssen HHW, Baars LGM, et al. 1988. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anti-coagulant activity. Br J Pharmacol 95:675-682.
69. Tillner I, Majewski F. 1978. Furrows and dermal ridges of the hand in patients with alcohol embryopathy. Hum Genet 42:307-314.
70. VanOverloop D, Schnell RR, Harvey EA, Holmes LB. 1992. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years. Neurotoxicol Teratol 14:329-335.
71. Viljoen DL. 1995. Porencephaly and transverse limb defects following severe maternal trauma in early pregnancy. Clin Dysmorphol 4:75-78.
72. Wells PG, Nagri MK, Grego GS. 1989. Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: a unifying hypothesis for the teratogenic effects of hydantoin anticonvulsants and structurally related compounds. Toxicol Appl Pharm 97:406-414.